Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial…
By G. Patti, M. Chello, Dario Candura, V. Pasceri, A. D’Ambrosio, E. Covino, G. Di Sciascio. Circulation, 2006
613 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/f3c73eb27cf7331048a338646b16dd43dd0b508e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Surgery
Citations in the corpus
- 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. (2014, neutral): “Statin therapy may be reasonable for primary prevention of new-onset AF after coronary artery surgery (151, 152).”
- Guidelines on myocardial revascularization. (2010, neutral): “IIa B [187,188]”
- 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesi (2011, background): “In addition, preoperative statin use has een associated with reduced rates of postoperative atrial brillation (AF) (571,572), neurological dysfunction (555, 73,574), renal dysfunction (575), and infection (576).”